BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 19054165)

  • 21. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy.
    Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S
    World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
    Giannarini G; Schumacher MC; Thalmann GN; Bitton A; Fleischmann A; Studer UE
    BJU Int; 2007 Aug; 100(2):264-8. PubMed ID: 17532855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH; Choi WS; Kwak C; Kim HH
    Urol Oncol; 2011; 29(4):383-7. PubMed ID: 19556154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma.
    Jou YC; Tung CL; Tsai YS; Shen CH; Syue-Yi C; Shiau AL; Tsai HT; Wu CL; Tzai TS
    Urology; 2009 Oct; 74(4):951-7. PubMed ID: 19679339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
    Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
    Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy.
    Abe T; Shinohara N; Harabayashi T; Sazawa A; Akino T; Ishikawa S; Kubota K; Matsuno Y; Osawa T; Shibata T; Toyoda Y; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
    BJU Int; 2010 Apr; 105(8):1102-6. PubMed ID: 19725822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
    Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
    J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
    Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F
    Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical character of renal transplant recipients with bilateral native upper urinary transitional cell carcinoma].
    Zhang P; Wang Y; Zhang XD; Hu XP; Wang W; Zhang Y; Yin H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):248-50. PubMed ID: 19552841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
    Jeldres C; Lughezzani G; Sun M; Isbarn H; Shariat SF; Budaus L; Lattouf JB; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2010 Apr; 183(4):1324-9. PubMed ID: 20171666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
    Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O
    Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
    Sanderson KM; Rouprêt M
    BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study.
    Berod AA; Colin P; Yates DR; Ouzzane A; Audouin M; Adam E; Arroua F; Marchand C; Bigot P; Soulié M; Roumiguié M; Polguer T; Gardic S; Grès P; Ravier E; Neuzillet Y; Delage F; Bodin T; Pignot G; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt C):E1035-40. PubMed ID: 22568669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
    Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.